Simplex Trading
RVMD icon

Simplex Trading’s Revolution Medicines RVMD Stock Holding History

Simplex Trading’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-9,644
Closed -$974K – 10003
2025
Q4 		$768K Buy
+9,644
New +$632K ﹤0.01% 2886
2024
Q3 		– Sell
-17,344
Closed -$755K – 9426
2024
Q2 		$673K Buy
17,344
+7,695
+80% +$288K ﹤0.01% 3343
2024
Q1 		$310K Buy
9,649
+1,147
+13% +$34K ﹤0.01% 4351
2023
Q4 		$243K Buy
+8,502
New +$204K ﹤0.01% 4471
2023
Q3 		– Sell
-328
Closed -$9.73K – 9660
2023
Q2 		$8K Sell
328
-3
-0.9% -$74 ﹤0.01% 7606
2023
Q1 		$7K Sell
331
-1,336
-80% -$32.9K ﹤0.01% 7844
2022
Q4 		$39K Buy
1,667
+276
+20% +$5.87K ﹤0.01% 6182
2022
Q3 		$27K Buy
1,391
+1,340
+2,627% +$29.4K ﹤0.01% 7195
2022
Q2 		$0 Sell
51
-600
-92% -$11.7K ﹤0.01% 10924
2022
Q1 		$16K Buy
+651
New +$14.2K ﹤0.01% 8481
2021
Q4 		– Sell
-1,070
Closed -$30.2K – 11313
2021
Q3 		$35K Hold
1,070
– – ﹤0.01% 7958
2021
Q2 		$33K Buy
+1,070
New +$37.3K ﹤0.01% 8143
2021
Q1 		– Sell
-701
Closed -$31.4K – 9858
2020
Q4 		$27K Buy
+701
New +$27.7K ﹤0.01% 6757

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Simplex Trading's RVMD Position: Q1 2026 in Review

Simplex Trading sold out of Revolution Medicines (RVMD) in Q1 2026, closing a stake of 9,644 shares — an estimated $974K sold.

Simplex Trading first reported a position in RVMD in Q4 2020 and held it in 13 quarters. The position peaked at $768K in Q4 2025. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • Simplex Trading reported no remaining Revolution Medicines position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 9,644 Revolution Medicines shares in Q1 2026, an estimated $974K.
  • Simplex Trading first reported a position in Revolution Medicines in Q4 2020 and held it in 13 quarters.
  • Simplex Trading's Revolution Medicines position peaked at $768K in Q4 2025.
  • 512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.